Trial Profile
Open randomised prospective comparative multi-centre intervention study of patients with cystic fibrosis and early diagnosed diabetes mellitus.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 09 Nov 2021
Price :
$35
*
At a glance
- Drugs Repaglinide (Primary) ; Insulin
- Indications Diabetes mellitus
- Focus Therapeutic Use
- 01 Dec 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 18 Oct 2011 Assistance Publique Hopitaux de Paris and Mukoviszidose Institut added in associations field as reported by ClinicalTrials.gov.
- 08 Jul 2010 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.